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Background: Commercially available xenograft blocks, claim to have adequate characteristics to interact with bio-
logical media and thus permitting biological fluid absorption. The objective of this in vitro study was to compare 
the blood absorption capacity of four different xenograft block materials of different composition of collagen and 
porosity. 
Material and Methods: Four brands of xenograft block materials were used (NuOss®, Bio-Oss®, Osteobiol® and 
Smartbone®). Five samples of each brand were analyzed, making a total of 20 tests. Human blood was used as 
the absorption liquid for the present experiment. The time period, in which the block remains in contact with the 
blood, was registered at 30 seconds (T1), 60 seconds (T2) and 5 minutes (T3). The xenograft blocks were evaluated 
according to their absorption capacity. 
Results: The absorption capacity of the different biomaterials were statistical significant different (p<0,001) at T1, 
T2 and T3 time points. At 30 seconds, Smartbone® absorbed significantly less blood than NuOss® and Bio-Oss®, 
however, without differences comparing with Osteobiol®. The NuOss®, Bio-Oss® and Osteobiol® did not regis-
ter any significant difference between them. At 60 seconds, the Smartbone® absorbed significantly less blood than 
the other biomaterials. 
Conclusions: The NuOss® was significantly superior than Osteobiol®, but without differences relatively with 
Bio-Oss®. Also the Bio-Oss® and Osteobiol® did not register any difference between them. At 5 minutes, the 
Smatbone® continued to significantly absorbed less blood than any other biomaterial, nevertheless, NuOss®, Bio-
Oss® and Osteobiol® not register again any significant difference between them. Despite of small sample size, it 
can be concluded that NuOss® was superior, in terms of blood absorption capacity, comparing with the other block 
biomaterials at 30 seconds, 60 seconds and 5 minutes. However, more investigation in a clinical setting are needed 
to know the clinical implications of the absorption capacity of such biomaterials.
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Introduction
The use of particulated xenografts in combination with 
resorbable membranes is the most well-documented te-
chnique for the regeneration of localized alveolar bone 
defects (1-3). Moreover, the survival of implants placed 
in regenerated bone is comparable to those placed in na-
tive bone (4,5). However, when particulated grafts are 
used, mechanical stability can be compromised (6). In 
such situations, the use of either non-resorbable devices 
or autogenous bone blocks are recommended (7,8). On 
the other hand, some clinical disadvantages such as the 
need of a donor surgical site and removal of the non-re-
sorbable device are associated with these techniques 
(9,10). Recent investigations are showing promising re-
sults, both in clinical and preclinical settings with the 
use of bone substitutes materials in block format (11-19). 
However, some preclinical studies, reported connective 
tissue infiltration resulting in low levels of new bone for-
mation. Such infiltration was located at the outer surface 
of the blocks away from the recipient site. Furthermore, 
the percentage of new bone formation was scarce and 
limited at the bottom part of the blocks and at the in-
terface between the recipient bone and the block graft 
(14,18,19). Other clinical investigations with the use of 
interpositioned xenograft blocks, showed more favora-
ble results in terms of volume stability and percentage of 
new bone formation (15,20). Scarano et al. reported that 
most of the graft particles that were interpositioned in 
inlay regeneration, were infiltrated by biological fluids 
and filled with newly formed bone, achieving a percen-
tage of new bone formation of 44% (20). Therefore, in 
vivo osteoconduction property of xenograft biomaterials 
may be influenced by an adequate structural characteri-
zation of bone substitute biomaterials that enhance the 
interaction between the biomaterial and biological me-
dia that ultimately favors the absorption of biological 
fluids and cell penetration (21-24).
Wettability is the ability of any solid surface to be wetted 
when in contact with a liquid, and therefore, is an impor-
tant characterization of biomaterials that can influence 
their absorption capacity of biological fluids (24).
Commercially available xenograft blocks, claim to have 
adequate characteristics to interact with biological me-
dia and thus permitting biological fluid absorption. The-
refore, the objective of the present pilot study was to 
quantify the absorption capacity of some commercially 
available xenograft bone blocks.
Material and Methods
This study was performed in the laboratory of Facultat 
d’Odontologia of Universitat Internacional de Catalunya.
Due to the fact that there are no previous studies about 
this subject, a pilot study with small sample size was 
designed.
Only xenograft blocks were analyzed to reduce bias. The 
following brands were evaluated: NuOss® (ACE Surgi-
cal Supply Company Inc., USA), Bio-Oss® (Geistlich 
Pharma AG, Switzerland), OsteoBiol® (Tecnoss, Italy) 
and Smartbone® (Ibi SA, Switzerland) (Fig. 1). Five 
samples of each material brand were analyzed, making a 
total of 20 observations. Each brand presented different 
commercially available block sizes. The block size of 
each block was selected in order to be similar to each 
other (NuOss® 8X9X9 mm,  Bio-Oss® 0.2-0.3 cm3, Os-
teoBiol® 10X10X10 mm and Smartbone® 10X10X10 
mm). Most of them were bovine origin except for Osteo-
Biol® which was equine origin. Smartbone® block graft 
was composed by bovine particles mixed with resorba-
Fig. 1: From A to D, block specimens before starting the study. A, bovine-80%; B, bovine-63%; C, bovine-27%; and D, equine-33%. 
From E to H, block specimens after the experiment.
J Clin Exp Dent. 2019;11(11):e1018-24.                                                                                                                              Capacity of blood absorption of commercially available xenograft blocks
e1020
ble polymers. The blocks presented with different per-
centage of collagen fragments: NuOss® 5%,  Bio-Oss® 
10%, OsteoBiol® 35% and Smartbone® some particles. 
The total porosity of each block was also different be-
tween brands: NuOss® 80%,  Bio-Oss® 63.5%, Osteo-
Biol® 33.1% and Smartbone® 27% .A specific name for 
each brand was designated related to its characteristics: 
bovine-80% (NuOss®), bovine-63% (Bio-Oss®), equi-
ne-33% (OsteoBiol®) and bovine-27% (Smartbone®).
The absorbent liquid used in the present study was hu-
man blood. The blood was collected using tubes with an 
anticoagulant solution of potassium citrate in order to 
avoid coagulation.
The method of measure the differences in weight was 
using a precision scale (Sartorius Extend Analytical Ba-
lances) with the precision of 0.0001 grams. In order to 
minimize the noise in the balance and making it very 
sensitive to changes in weight, a method of weighting 
described in the literature was used (21). It consisted in 
fixing the sample in a light weight structure located on 
the precision scale (Fig. 2), then the blood was brought 
Fig. 2: Light weight device holding the biomaterial and placed on top 
of the precision scale.
into contact by a movable stage outside the precision 
scale. Previously, the lightweight structure was weighted 
and tared to 0 value. Then, the sample was fixed at the 
lightweight structure in order to measure the initial wei-
ght of the blocks, before starting the experiment. When 
blood contacted the sample, the movable stage was sto-
pped. With this method, the increases in weight could be 
observed and registered and since the sample was held 
in a constant position there were negligible buoyancy 
effects (18). As the experiment continues, the samples 
increased their weight as more liquid was drawn into the 
pores of the material. 
The time period, in which the block remained in contact 
with the blood, was measured with a stopwatch, after 30 
seconds (T1), 60 seconds (T2) and 5 minutes (T3). The 
weight was recorded in each time interval. This process 
was repeated with the different blocks that were analyzed.
-Statistical analysis
Due to the exploratory nature of this study, no sample 
size calculation was performed. Statistical analyses 
were performed using a nonparametric model of Brun-
ner-Langer and post-hoc comparisons with Bonferroni 
corrections. A SPSS15.0® and R.3.0.2® programs were 
used, with a significance level of 5% (α=0.05).
Results
General results of the different weights after the obser-
vation time points are shown in Table 1. In Figure 1, are 
shown the aspect of the blocks after the experiment. In 
Table 2 are shown the mean gain the different groups 
between T0 and the different time points (T1, T2 and 
T3). Also, in order to help visualize the changes between 
groups and the different time points, the initial weights 
were normalized to 1 value (Table 3).
 Bovine-80% Bovine-63% Bovine-27% Equine-33%
T0 0.3 ± 0.026 0.130 ± 0.010 0.7560 ± 0.302 0.473 ± 0.043
T1 0.578 ± 0.041 0.147 ± 0.012 0.815 ± 0.289 0.587 ± 0.034
T2 0.663 ± 0.055 0.150 ± 0.011 0.827 ± 0.276 0.611 ± 0.045 
T3 0.77 ± 0.052 0.157 ± 0.012 0.833 ± 0.266 0.811 ± 0.071 
Table 1: Mean values and standard deviation of the different weights obtained at the different time points. Values expressed in mili-
grams (mg).
 Bovine-80% Bovine-63% Bovine-27% Equine-33%
T0-T1 0.279 ± 0.026 0.016 ± 0.005 0.059 ± 0.03 0.114 ± 0.03
T0-T2 0.363 ± 0.05 0.019 ± 0.005 0.071 ± 0.04 0.137 ± 0.05
T0-T3 0.469 ± 0.02 0.026 ± 0.006 0.077 ± 0.06 0.30 ± 0.12 
Table 2: Differences of weights between T0 and the different time points: T1, T2 and T3. Values expressed in mg.
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 Bovine-80% Bovine-63% Bovine-27% Equine-33%
T0-T1 1.934 ± 0.107 1.123 ± 0.041 1.102 ± 0.11 1.246 ± 0.07
T0-T2 2.225 ± 0.26 1.15 ± 0.042 1.128 ± 0.14 1.297 ± 0.122
T0-T3 2.57 ± 0.068 1.206 ± 0.05 1.146 ± 0.186 1.654 ± 0.28 
Table 3: Differences of weights of the different groups at different time points with normalized initial weight to 1. Values expressed 
in mg.
A box plot graph was elaborated to exhibit the distri-
bution of the weight values between groups and time 
observations (Fig. 3). It can be observed in such graph 
that the bovine-63% and bovine-27% groups present a 
limited absorption capacity, since the weight values re-
main stable throughout the observation times. However, 
it is only a visual impression, due to the lighter initial 
weights of the bovine-63%.
The global changes of the biomaterials were also 
analyzed. Such analysis was divided into three different 
sections corresponding to the three time points evaluated 
at T1, T2 and T3.
At 30 seconds (T0-T1)
Between T0 and T1, the blocks changed significant-
ly their weight, meaning that there is a time effect 
(p<0.001). However, the gain of weight is not homoge-
neous between the groups. An interaction effect exists 
(p<0.001). In Table 4 are shown the comparisons of the 
Fig. 3: Box plot graph with the distribution of the weights of the different biomaterials at different 
time intervals.
weight change between the period T0-T1. It can be noti-
ced that the bovine-80% and bovine-63% absorbed sig-
nificantly more blood than bovine-27%. No significant 
differences were observed between bovine-80% and bo-
vine-63% (p=0.239). The equine-33% did not registered 
any significant differences when compared with all of 
the other biomaterials.
At 60 seconds (T0-T2)
Between T0 and T2, the blocks change significantly 
their weight, showing again the time effect (p<0.001). 
However, the magnitude of this alteration was diffe-
rent according with the type of biomaterial (p<0.001). 
The bovine-27% absorbed significantly less blood 
than the others. The bovine-80% blocks were signifi-
cantly superior to equine-33% (p=0.00017). The equi-
ne-33% was significant superior to bovine-27% but 
without differences when compared with bovine-63% 
(Table 4).



























































































































































































































































































































At 5 minutes (T0-T3)
Between T0 and T3, the blocks change significant-
ly their weight (p<0.001). However, the magnitude of 
this alteration was different according with the type of 
biomaterial (p<0.001). The bovine-27% absorbed sig-
nificantly less blood than the others. The bovine-80%, 
the bovine-63% and the equine-33% did not present any 
significant difference between them (Table 4). Also, des-
pite of the significant differences between equine-33% 
and bovine-80% at T2, favoring the later, they did not 
register any significant differences at T3 due to the big 
absorption capacity of the equine-33% between T2 and 
T3. These differences became more equal after 5 minu-
tes, although more favorable results for the bovine-80% 
group (p=0.024).
Global study model (T0, T1, T2 and T3)
The blocks increased significantly their weights throu-
ghout the entire period of the experiment (p<0.001). 
However, with a different pattern depending on the bio-
material (p<0.001). The change of weight between T0 
and T1 were weaker in bovine-63% and bovine-27% 
groups when comparing with bovine-80% and equi-
ne-33%. The bovine-80%, despite started the initial 
weight lower than equine-33%, at T1, their weights had 
become equal and even at T2, bovine-80% was higher 
than equine-33%. Finally, both weights at T3 were pro-
portional to T0.
Although mechanical stability of the blocks was not 
part of the objective of the present study, the bovi-
ne-80% blocks changed their shape after the experiment, 
showing a lack of mechanical stability. However, all of 
the other blocks did not change the form and remained 
stable from the beginning.
Discussion 
Up to the author’s knowledge, no similar studies were 
published in the literature, therefore comparisons with 
other studies could not be made.
All the blocks used in the present study are commercia-
lly available and were not manufactured for the study.
One of the limitations of the study was the small sam-
ple size. However, this pilot study showed interesting 
results in regard of the blood absorption of the different 
xenograft blocks. Generally, all blocks augment their 
weight during the experiment (p<0.001). However, 
this increment in weight was different between the test 
groups (p<0.001). At T1, bovine-80% and bovine-63% 
are clearly superior than bovine-27%. Meanwhile, equi-
ne-33% tends to have the same absorption capacity than 
bovine-80% and bovine-63%, but with less magnitude. 
These differences observed at a very short period of 
time, can indicate a superior advantage of bovine-80% 
and bovine-63% over the other biomaterials since early 
blood-mediated inflammatory response triggers the cas-
cade of initial bone repair (25,26). Results of the weight 
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gain at T2 and T3 of the different test groups reveled that 
bovine-27% was the block with less absorption capacity. 
The absorption capacity is more progressive and linear 
for bovine-80% while the equine-33% highlights a no-
ticeable weight gain between T2 and T3. Equine-33% 
group tends to a more important absorption capacity 
than bovine-63% group. Bovine-80%, revealed to be the 
most effective biomaterial for the blood absorption ca-
pacity, since it is significantly better than bovine-27% 
at any time and globally exhibiting a strong tendency to 
overcome bovine-63% and equine-33%. 
These differences in blood absorption capacity, may affect 
the percentage of new bone formation during guided bone 
regeneration (22,24). In clinical studies, this formation in 
block bone substitute grafts, basically is found at the in-
terface between the block and the recipient site and usua-
lly tends to be around 5.9% (19). However, when the xe-
nografts blocks are interpositioned, where two bone walls 
are present, the percentage of new vital bone tends to rise 
up till 44%, without gaps nor connective tissue between 
the biomaterial and bone interface (20). These findings, 
reinforce the idea that, enhanced blood absorption capaci-
ty of blocks will make them less dependent on the amount 
of blood supply sources of the defect sites. 
Wettability is not the only characteristic that can influen-
ce blood absorption capacity of biomaterials, also, mi-
cro and macro-porosity, can influence as well (27).  Al-
though the present study was not designed to relate the 
blood absorption capacity with such factors, it could be 
observed a proportional relation between them, since the 
groups with higher percentage of total porosity obtai-
ned higher values of blood absorption. This can have an 
important clinical implication because it is known that 
increased porosity facilitate bone ingrowth (23). On the 
other side, as reported in the literature, if total porosity 
is increased it may affect the mechanical strength of the 
biomaterial (23). Despite not being the objective of the 
study, we could corroborate that bovine-80% and bovi-
ne-63% blocks with higher percentages of total porosity, 
their shape and integrity were slightly deformed at T3. 
Therefore, the use of these blocks could not be used in 
non-contained defects, but instead, it would be more re-
asonable to use them in contained defects such as socket 
preservation.
Within the limitations of this pilot study it can be con-
cluded that the blood absorption of the different groups 
increased over time. However, with a different magni-
tude depending on the biomaterial. Bovine-83% group 
appears to be the most effective, followed by equi-
ne-33% and bovine-63%. The latter two groups having 
no significant differences between them. Bovine-27% 
exhibit the poorest results in terms of blood absorption. 
More in-vitro and in-vivo studies are required to ascer-
tain the clinical implications of absorption capacity of 
bone substitute grafts in alveolar bone regeneration. 
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